German Merck also received an undisclosed milestone payment and will be eligible for development and commercial milestone ... to Novartis’ blockbuster Cosentyx (secukinumab) and clinical ...

Cosentyx (secukinumab) may be safe to use while pregnant or breastfeeding. Before starting treatment, you and your doctor can discuss the risks and benefits of Cosentyx treatment during pregnancy ...

Bimekizumab performed better than Cosentyx across all the primary and ... budgets,” and suggests that UCB may now seek out a commercial partner to give it more marketing muscle.